These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 10485654)

  • 21. CD22 is a negative regulator of B-cell receptor signalling.
    Nitschke L; Carsetti R; Ocker B; Köhler G; Lamers MC
    Curr Biol; 1997 Feb; 7(2):133-43. PubMed ID: 9016707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD19 and CD22 regulate a B lymphocyte signal transduction pathway that contributes to autoimmunity.
    Tedder TF; Sato S; Poe JC; Fujimoto M
    Keio J Med; 2000 Mar; 49(1):1-13. PubMed ID: 10750375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Defective negative regulation of antigen receptor signaling in Lyn-deficient B lymphocytes.
    Chan VW; Lowell CA; DeFranco AL
    Curr Biol; 1998 May; 8(10):545-53. PubMed ID: 9601638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection.
    Cornall RJ; Cyster JG; Hibbs ML; Dunn AR; Otipoby KL; Clark EA; Goodnow CC
    Immunity; 1998 Apr; 8(4):497-508. PubMed ID: 9586639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of B cell receptor-associated signaling molecules in human lupus.
    Huck S; Le Corre R; Youinou P; Zouali M
    Autoimmunity; 2001 May; 33(3):213-24. PubMed ID: 11683380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of p72syk kinase, p53/56lyn kinase and phosphatidyl inositol-3 kinase in signal transduction via the human B lymphocyte antigen CD22.
    Tuscano JM; Engel P; Tedder TF; Agarwal A; Kehrl JH
    Eur J Immunol; 1996 Jun; 26(6):1246-52. PubMed ID: 8647200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cognate B cell signaling via MHC class II: differential regulation of B cell antigen receptor and MHC class II/Ig-alpha beta signaling by CD22.
    Mills DM; Stolpa JC; Cambier JC
    J Immunol; 2004 Jan; 172(1):195-201. PubMed ID: 14688326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD19 signaling pathways play a major role for murine AIDS induction and progression.
    Knoetig SM; Torrey TA; Naghashfar Z; McCarty T; Morse HC
    J Immunol; 2002 Nov; 169(10):5607-14. PubMed ID: 12421939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ST6Gal-I restrains CD22-dependent antigen receptor endocytosis and Shp-1 recruitment in normal and pathogenic immune signaling.
    Grewal PK; Boton M; Ramirez K; Collins BE; Saito A; Green RS; Ohtsubo K; Chui D; Marth JD
    Mol Cell Biol; 2006 Jul; 26(13):4970-81. PubMed ID: 16782884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Negative regulation of B cell receptor-mediated signaling in B-1 cells through CD5 and Ly49 co-receptors via Lyn kinase activity.
    Ochi H; Watanabe T
    Int Immunol; 2000 Oct; 12(10):1417-23. PubMed ID: 11007759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Definition of the sites of interaction between the protein tyrosine phosphatase SHP-1 and CD22.
    Blasioli J; Paust S; Thomas ML
    J Biol Chem; 1999 Jan; 274(4):2303-7. PubMed ID: 9890995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD22, a B lymphocyte-specific adhesion molecule that regulates antigen receptor signaling.
    Tedder TF; Tuscano J; Sato S; Kehrl JH
    Annu Rev Immunol; 1997; 15():481-504. PubMed ID: 9143697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tuning antigen receptor signaling by CD22: integrating cues from antigens and the microenvironment.
    Cyster JG; Goodnow CC
    Immunity; 1997 May; 6(5):509-17. PubMed ID: 9175829
    [No Abstract]   [Full Text] [Related]  

  • 34. The ligand-binding domain of CD22 is needed for inhibition of the B cell receptor signal, as demonstrated by a novel human CD22-specific inhibitor compound.
    Kelm S; Gerlach J; Brossmer R; Danzer CP; Nitschke L
    J Exp Med; 2002 May; 195(9):1207-13. PubMed ID: 11994426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hematopoietic cell phosphatase is recruited to CD22 following B cell antigen receptor ligation.
    Lankester AC; van Schijndel GM; van Lier RA
    J Biol Chem; 1995 Sep; 270(35):20305-8. PubMed ID: 7657601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of tyrosine phosphorylation-dependent interactions between stimulatory effector proteins and the B cell co-receptor CD22.
    Yohannan J; Wienands J; Coggeshall KM; Justement LB
    J Biol Chem; 1999 Jun; 274(26):18769-76. PubMed ID: 10373493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lyn/CD22/SHP-1 and their importance in autoimmunity.
    Blasioli J; Goodnow CC
    Curr Dir Autoimmun; 2002; 5():151-60. PubMed ID: 11826756
    [No Abstract]   [Full Text] [Related]  

  • 38. CD19 amplifies B lymphocyte signal transduction by regulating Src-family protein tyrosine kinase activation.
    Fujimoto M; Poe JC; Jansen PJ; Sato S; Tedder TF
    J Immunol; 1999 Jun; 162(12):7088-94. PubMed ID: 10358152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD19 regulates intrinsic B lymphocyte signal transduction and activation through a novel mechanism of processive amplification.
    Fujimoto M; Poe JC; Hasegawa M; Tedder TF
    Immunol Res; 2000; 22(2-3):281-98. PubMed ID: 11339363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Counterregulation by the coreceptors CD19 and CD22 of MAP kinase activation by membrane immunoglobulin.
    Tooze RM; Doody GM; Fearon DT
    Immunity; 1997 Jul; 7(1):59-67. PubMed ID: 9252120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.